Cargando…
Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
Endometrial carcinoma (EnCa) is one of the deadliest gynecological malignancies. The purpose of the current study was to develop an immune-related lncRNA prognostic signature for EnCa. In the current research, a series of systematic bioinformatics analyses were conducted to develop a novel immune-re...
Autores principales: | Liu, Jinhui, Mei, Jie, Wang, Yichun, Chen, Xucheng, Pan, Jiadong, Tong, Laigen, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893582/ https://www.ncbi.nlm.nih.gov/pubmed/33613104 http://dx.doi.org/10.7150/ijbs.51207 |
Ejemplares similares
-
Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021) -
Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021) -
Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021) -
Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes
por: Liu, Jinhui, et al.
Publicado: (2021) -
Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma
por: Zhou, Xin-Ying, et al.
Publicado: (2022)